ATS 2024 ARDS Guideline Update: Corticosteroids, VV-ECMO, NMBAs and PEEP Strategies Reappraised
For Critical Care / ICU pharmacists, this update adds the first ATS conditional recommendations for systemic corticosteroids and neuromuscular blockade in ARDS, with specific implications for agent selection, duration, and monitoring.
📅 Journal publication: Jan 1, 2024·Last updated: Nov 18, 2026
New guidelines offer updated strategies for ARDS management.
The guidelines provide updated management strategies for adult patients with acute respiratory distress syndrome (ARDS). Conditional recommendations for corticosteroids, VV-ECMO in selected severe ARDS, neuromuscular blockers in early severe ARDS, and higher PEEP without lung recruitment maneuvers in moderate-to-severe ARDS. These guidelines offer actionable insights for optimizing ARDS treatment in critical care settings, although real-world adaptation may vary. Updated guidelines refine ARDS management with evidence-based recommendations for optimal patient outcomes.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Qadir N, Sahetya S, Munshi L, Summers C, Abrams D, Beitler J, Bellani G, Brower RG, Burry L, Chen JT, Hodgson C, Hough CL, Lamontagne F, Law A, Papazian L, Pham T, Rubin E, Siuba M, Telias I, Patolia S, Chaudhuri D, Walkey A, Rochwerg B, Fan E
Citation:Qadir N, Sahetya S, Munshi L, et al. An Update on Management of Adult Patients with Acute Respiratory Distress Syndrome: An Official American Thoracic Society Clinical Practice Guideline. American journal of respiratory and critical care medicine. 2024;209(1):24-36. doi:10.1164/rccm.202311-2011ST